The Arab Drug Company (EGX:ADCI)

Egypt flag Egypt · Delayed Price · Currency is EGP
227.88
-0.19 (-0.08%)
At close: Oct 22, 2025
-0.08%
Market Cap2.76B
Revenue (ttm)1.03B
Net Income (ttm)158.78M
Shares Out12.00M
EPS (ttm)13.23
PE Ratio17.39
Forward PEn/a
Dividend4.17 (1.83%)
Ex-Dividend DateOct 28, 2025
Volume23,701
Average Volume41,910
Open228.07
Previous Close228.07
Day's Range220.00 - 239.00
52-Week Range50.00 - 229.97
Beta0.60
RSI82.86
Earnings DateNov 24, 2025

About The Arab Drug Company

The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. It offers anti-infectives, central nervous system drugs, dermatological drugs, and cardiovascular drugs, as well as animal health products in powders and solutions. The company exports its products to approximately 40 countries, including China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco. The Arab Drug Company was incorporated in 1963 and is based in Cairo, Egypt. [Read more]

Industry Pharmaceutical Preparations
Founded 1963
Employees 1,152
Stock Exchange Egyptian Stock Exchange
Ticker Symbol ADCI
Full Company Profile

Financial Performance

In 2024, The Arab Drug Company's revenue was 785.52 million, an increase of 23.95% compared to the previous year's 633.73 million. Earnings were 88.35 million, an increase of 24.21%.

Financial Statements

News

There is no news available yet.